Pharmaceuticals News
Source: Google
Pharmaceuticals News
BioCryst Pharmaceuticals (NASDAQ:BCRX)
BioCryst Pharmaceuticals (NASDAQ:BCRX) Trading Up 6% - What's Next? MarketBeat
Posted on 11 August 2026 | 10:03 am
ARS Pharmaceuticals Investors Face October
ARS Pharmaceuticals Investors Face October Lawsuit Deadline stl.news
Posted on 11 August 2026 | 9:57 am
BioCryst Pharmaceuticals (BCRX) Could Be 54%
BioCryst Pharmaceuticals (BCRX) Could Be 54% Undervalued Following Strong Earnings Guidance simplywall.st
Posted on 11 August 2026 | 9:39 am
Jazz Pharmaceuticals (JAZZ) Acquires Actio
Jazz Pharmaceuticals (JAZZ) Acquires Actio Biosciences for $820 Million GuruFocus
Posted on 11 August 2026 | 9:35 am
Medincell’s Dr Grace Kim to Participate in
Medincell’s Dr Grace Kim to Participate in Piper Sandler CNS Symposium Business Wire
Posted on 11 August 2026 | 9:30 am
Source: Yahoo
Pharmaceuticals News
Bronstein, Gewirtz & Grossman LLC Urges
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm PR Newswire
Posted on 11 August 2026 | 9:00 am
Jazz Pharmaceuticals' Actio Acquisition
Jazz Pharmaceuticals' Actio Acquisition 'Makes Sense,' Has Good Synergy, RBC Says marketscreener.com
Posted on 11 August 2026 | 8:46 am
Jazz Pharmaceuticals' Actio Acquisition
Jazz Pharmaceuticals' Actio Acquisition 'Makes Sense,' Has Good Synergy, RBC Says Yahoo Finance
Posted on 11 August 2026 | 8:42 am
Syndax Pharmaceuticals (NASDAQ:SNDX) Given
Syndax Pharmaceuticals (NASDAQ:SNDX) Given New $40.00 Price Target at JPMorgan Chase & Co. MarketBeat
Posted on 11 August 2026 | 8:17 am
SPRY DEADLINE: The Gross Law Firm Reminds
SPRY DEADLINE: The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline PR Newswire
Posted on 11 August 2026 | 8:02 am
Source: Bing
Pharmaceuticals News
Demand drives pharmaceutical earnings in
Demand drives pharmaceutical earnings in H1'26 CNBC Africa
Posted on 11 August 2026 | 8:01 am
Jazz Pharmaceuticals to acquire Actio
Jazz Pharmaceuticals to acquire Actio Biosciences for $820 million, expanding rare epilepsy portfolio CNBC
Posted on 11 August 2026 | 7:58 am
SPRY Investors Have Opportunity to Lead ARS
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law WBOC TV
Posted on 11 August 2026 | 7:46 am
Does TrumpRx's Price Talk Match Patient
Does TrumpRx's Price Talk Match Patient Savings? Pharmaceutical Commerce
Posted on 11 August 2026 | 7:44 am
Implied Volatility Surging for BioCryst
Implied Volatility Surging for BioCryst Pharmaceuticals Stock Options Yahoo Finance
Posted on 11 August 2026 | 7:43 am